KRM Ayurveda IPO GMP, Subscription & Allotment Status Today
KRM Ayurveda is a SME IPO with a price band of Rs 128.00 to Rs 135.00 that listed on 29 Jan 2026 at a listing gain of +27.48%. Track its full GMP history, subscription data and listing details here.
- Price Band
- ₹128.00 - ₹135.00
- Lot Size
- 1,000 Shares
- Bidding Closes
- 23 Jan 2026
- Listing Date
- 29 Jan 2026
Complete IPO information
| Current GMP | ₹37.1 |
|---|---|
| Estimated Listing Gain | +27.48% |
| Price Band | ₹128.00 - ₹135.00 |
| Issue Price | Approx ₹135.00 Crores |
| Listing Price | ₹172.10 |
| Lot Size | 1,000 Shares |
| Issue Type | SME |
| Registrar | TBA |
| Exchange | NSE, BSE |
| Retail Quota | TBA |
| Overall Subscription | TBA |
| Listing Date | 29 Jan 2026 |
| Minimum Investment | ₹2,70,000 |
Compare KRM Ayurveda IPO with similar IPOs
IPO Snapshot & Investor Takeaways
At the upper end of its price band, KRM Ayurveda is priced at ₹135 per share. With a minimum lot size of 1,000 shares, a retail investor applying for one lot would need approximately ₹2,70,000 to participate in this SME issue.
The latest recorded Grey Market Premium for KRM Ayurveda stands at ₹37.1, implying an estimated listing gain of around 27.48% over the issue price if it holds until listing. This is up ₹4.5 from its previously recorded level. GMP reflects informal grey-market sentiment rather than a guaranteed outcome, and can change at any point until the day of listing.
SME IPOs list on the dedicated SME platform of BSE/NSE. They usually involve smaller issue sizes and a higher per-lot investment than Mainboard issues, with comparatively lower institutional participation.
IPO roadmap at a glance
Daily GMP status
| Date | GMP | Change | Gain |
|---|---|---|---|
| 29 Jan 2026 | ₹23.00 | +₹4.50 | 17.04% |
| 27 Jan 2026 | ₹18.50 | +₹2.50 | 13.70% |
| 26 Jan 2026 | ₹16.00 | +₹4.00 | 11.85% |
| 22 Jan 2026 | ₹12.00 | -₹9.00 | 8.89% |
| 21 Jan 2026 | ₹21.00 | +₹1.00 | 15.56% |
| 19 Jan 2026 | ₹20.00 | +₹5.00 | 14.81% |
| 16 Jan 2026 | ₹15.00 | - | 11.11% |
Application size breakdown
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 2 Lot | 2,000 | ₹2,70,000 |
| Retail Maximum | 2 Lot | 2,000 | ₹2,70,000 |
| S-HNI Minimum | 3 Lot | 3,000 | ₹4,05,000 |
| S-HNI Maximum | 7 Lot | 7,000 | ₹9,45,000 |
| B-HNI Minimum | 8 Lot | 8,000 | ₹10,80,000 |
Objects of the Issue & Official Documents
KRM Ayurveda IPO – Key Details
| IPO Open Date | January 21, 2026 |
| IPO Close Date | January 23, 2026 |
| Face Value | ₹10 per Equity Share |
| Price Band | ₹128 – ₹135 per Share |
| Issue Size | Approx ₹77 Crores |
| Fresh Issue | Approx ₹77 Crores |
| Issue Type | Book Build Issue |
| IPO Listing | NSE SME |
KRM Ayurveda IPO – Market Lot Details
| Application | Lot Size | Shares | Amount (₹) |
|---|---|---|---|
| Retail Minimum | 2 | 2,000 | 2,70,000 |
| Retail Maximum | 2 | 2,000 | 2,70,000 |
| S‑HNI Minimum | 3 | 3,000 | 4,05,000 |
| S‑HNI Maximum | 7 | 7,000 | 9,45,000 |
| B‑HNI Minimum | 8 | 8,000 | 10,80,000 |
KRM Ayurveda IPO – Reservation Details
| Investor Category | Shares Offered | Percentage (%) |
|---|---|---|
| Anchor Investor | 15,87,000 | 27.65% |
| QIB (Ex. Anchor) | 10,62,000 | 18.50% |
| NII | 8,01,000 | 13.95% |
| Retail | 18,66,000 | 32.51% |
KRM Ayurveda IPO – Anchor Investors
| Anchor Bidding Date | January 20, 2026 |
| Anchor Investors List | – |
| Shares Offered to Anchor Investors | 15,87,000 Shares |
| Anchor Size | – |
| Lock‑in Period (50% Shares – 30 Days) | February 26, 2026 |
| Lock‑in Period (50% Shares – 90 Days) | April 27, 2026 |
KRM Ayurveda IPO – Important Dates
| IPO Open Date | January 21, 2026 |
| IPO Close Date | January 23, 2026 |
| Basis of Allotment | January 27, 2026 |
| Refunds Initiation | January 28, 2026 |
| Credit to Demat Account | January 28, 2026 |
| IPO Listing Date | January 29, 2026 |
| IPO Bidding Cut‑off Time | January 23, 2026 – 5:00 PM |
KRM Ayurveda IPO – Promoters & Holding Pattern
Promoters: Mr. Puneet Dhawan and Mrs. Tanya Dhawan
| Particulars | Shares | Shareholding (%) |
|---|---|---|
| Promoter Holding (Pre‑Issue) | 1,55,20,800 | 92.16% |
| Promoter Holding (Post‑Issue) | 2,12,60,800 | 67.28% |
KRM Ayurveda IPO – Objects of the Issue & Utilisation of Proceeds
| Purpose | Amount (₹ Cr) |
|---|---|
| Capital Expenditure for construction and development of Telemedicine operational facilities | 13.67 |
| Purchase of CRM software and hardware infrastructure | 1.42 |
| Human Resources | 5.44 |
| Repayment / Prepayment of loan | 12.50 |
| Working Capital Requirement | 18.00 |
| General Corporate Purpose | – |
About KRM Ayurveda IPO
KRM Ayurveda Ltd started its journey on 3 September 2019, with the work of manufacturing Ayurvedic products, herbal and botanical remedies, medicines, supplements, and possibly skin care / wellness-related items.
The company has many hospitals and clinics across India, not only in India, but it also provides telemedicine services and sales abroad. Presently, the company runs 6 (Six) Hospitals and 5 (Five) Clinics at different locations in the country. The company has good services for the patient, including In-Patient & Out-Patient Care, Panchakarma Therapies, Specialized Clinics, Medicinal Sales, Diet & Lifestyle Counseling.
Strengths:
- Skilled Ayurvedic doctors and trained therapists ensure quality treatment.
- The company is a trusted brand with loyal and repeat customers.
KRM Ayurveda IPO – Company Financial Report
| Period Ended | Revenue (₹ Cr) | Expense (₹ Cr) | PAT (₹ Cr) | Assets (₹ Cr) |
|---|---|---|---|---|
| FY 2023 | 89.38 | 79.29 | 7.60 | 39.48 |
| FY 2024 | 67.57 | 62.85 | 3.41 | 43.91 |
| FY 2025 | 76.95 | 60.61 | 12.10 | 66.79 |
| Sep 2025 | 48.65 | 37.65 | 8.14 | 78.12 |
KRM Ayurveda IPO – Valuation (FY2025)
| KPI | Values |
|---|---|
| ROE | 67.86% |
| ROCE | 43.33% |
| EBITDA Margin | 24.96% |
| PAT Margin | 15.80% |
| Debt to Equity Ratio | 1.31 |
| Earning Per Share (EPS) | ₹8.06 (Basic) |
| Price / Earnings (P/E) | N/A |
| Return on Net Worth (RoNW) | 67.86% |
| Net Asset Value (NAV) | ₹1,602.40 |
KRM Ayurveda IPO – Peer Group Comparison
| Company | EPS (₹) | P/E Ratio | RoNW (%) | NAV (₹) | Income (₹ Cr) |
|---|---|---|---|---|---|
| Jeena Sikho Lifecare Ltd. | 8.86 | 76.58 | 31.28% | 142.24 | 110.10 |
| Vaidya Sane Ayurved Laboratories Ltd. | 3.07 | 93.20 | 5.12% | 59.85 | 3.22 |
KRM Ayurveda IPO FAQs
Comments
Share a useful question or insight about KRM Ayurveda.
Leave a comment
Your email address will not be published. All comments and replies are reviewed before appearing.
Loading comments...